The genetics of pemphigus

Dermatologic Clinics

Volumn 29, Issue 3, 2011, Pages 381-391

  Sinha, Animesh A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Autoimmunity; Blistering disorders; Genetics; Pemphigus

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

AUTOIMMUNE SKIN DISEASE; BULLOUS SKIN DISEASE; CLINICAL DECISION MAKING; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOME; HEREDITY; HUMAN; PEMPHIGUS VULGARIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PEMPHIGUS; RISK FACTORS;

EID: 79956269707     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.03.020     Document Type: Review

References (70)

1. Becker B.A., Gaspari A.A. Pemphigus vulgaris and vegetans. Dermatol Clin 1993, 11:429-452.
2. Amagai M., Tsunoda K., Zillikens D., et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999, 40:167-170.
3. Anhalt G.J., Labib R.S., Voorhees J.J., et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982, 306:1189-1196.
4. Mahoney M.G., Wang Z., Rothenberger K., et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999, 103:461-468.
5. Kalantari-Dehaghi M., Molina D.M., Farhadieh M., et al. New targets of pemphigus vulgaris antibodies identified by protein array technology. Exp Dermatol 2011, 20:154-156.
6. Patel M., Furstenberg G., Hazelton J., et al. Development of protein microarrays to investigate autoantibody profiles in pemphigus vulgaris. J Invest Dermatol 2010, 130:S19. [abstract: 549].
7. Sinha A.A., Brautbar C., Szafer F., et al. A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science 1988, 239:1026-1029.
8. Sinha A.A., Lopez M.T., McDevitt H.O. Autoimmune diseases: the failure of self tolerance. Science 1990, 248:1380-1388.
9. Lee E., Lendas K.A., Chow S., et al. Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol 2006, 67:125-139.
10. Tron F., Gilbert D., Joly P., et al. Immunogenetics of pemphigus: an update. Autoimmunity 2006, 39:531-539.
11. Tron F., Gilbert D., Mouquet H., et al. Genetic factors in pemphigus. J Autoimmun 2005, 24:319-328.
12. Gazit E., Loewenthal R. The immunogenetics of pemphigus vulgaris. Autoimmun Rev 2005, 4:16-20.
13. Salmanpour R., Shahkar H., Namazi M.R., et al. Epidemiology of pemphigus in south-western Iran: a 10-year retrospective study (1991-2000). Int J Dermatol 2006, 45:103-105.
14. Asilian A., Yoosefi A., Faghini G. Pemphigus vulgaris in Iran: epidemiology and clinical profile. Skinmed 2006, 5:69-71.
15. Langan S.M., Smeeth L., Hubbard R., et al. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008, 337:a180.
16. Bystryn J.C., Rudolph J.L. Pemphigus. Lancet 2005, 366:61-73.
17. Nanda A., Dvorak R., Al-Saeed K., et al. Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004, 43:876-881.
18. Humbert P., Dupond J.L., Vuitton D., et al. Dermatological autoimmune diseases and the multiple autoimmune syndromes. Acta Derm Venereol Suppl (Stockh) 1989, 148:1-8.
19. Mohan M.P., Ramesh T.C. Multiple autoimmune syndrome. Indian J Dermatol Venereol Leprol 2003, 69:298-299.
20. Weetman A.P. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol (Oxf) 2011, 74(4):411-418.
21. Coda A.B., Qafalijaj Hysa V., Seiffert-Sinha K., et al. Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity. Genes Immun 2010, 11:531-541.
22. Subramanya R.D., Coda A.B., Sinha A.A. Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics 2010, 96:146-153.
23. Bordel-Gomez M.T., Sanchez-Estella J., Yuste-Chaves M., et al. Actas Dermosifiliogr 2006, 97:509-513. [in Spanish].
24. Laskaris G., Sklavounou A., Stavrou A., et al. Familial pemphigus vulgaris with oral manifestations affecting two Greek families. J Oral Pathol Med 1989, 18:49-53.
25. Katzenelson V., David M., Zamir R., et al. Familial pemphigus vulgaris. Dermatologica 1990, 181:48-50.
26. Feinstein A., Yorav S., Movshovitz M., et al. Pemphigus in families. Int J Dermatol 1991, 30:347-351.
27. Stavropoulos P.G., Zarafonitis G., Petridis A., et al. Pemphigus vulgaris in two sisters. Acta Derm Venereol 2001, 81:149.
28. Todd J.A., Acha-Orbea H., Bell J.I., et al. A molecular basis for MHC class II-associated autoimmunity. Science 1988, 240:1003-1009.
29. Szafer F., Brautbar C., Tzfoni E., et al. Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc Natl Acad Sci U S A 1987, 84:6542-6545.
30. Scharf S.J., Friedmann A., Brautbar C., et al. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A 1988, 85:3504-3508.
31. Shams S., Amirzargar A.A., Yousefi M., et al. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J Clin Immunol 2009, 29:175-179.
32. Brick C., Belgnaoui F.Z., Atouf O., et al. Pemphigus and HLA in Morocco. Transfus Clin Biol 2007, 14:402-406.
33. Saenz-Cantele A.M., Fernandez-Mestre M., Montagnani S., et al. HLA-DRB1*0402 haplotypes without DQB1*0302 in Venezuelan patients with pemphigus vulgaris. Tissue Antigens 2007, 69:318-325.
34. Slomov E., Loewenthal R., Goldberg I., et al. Pemphigus vulgaris in Jewish patients is associated with HLA-A region genes: mapping by microsatellite markers. Hum Immunol 2003, 64:771-779.
35. Tong J.C., Tan T.W., Sinha A.A., et al. Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris. BMC Bioinformatics 2006, 7(Suppl 5):S7.
36. Takahashi H., Amagai M., Nishikawa T., et al. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J Immunol 2008, 181:1526-1535.
37. Geng L., Wang Y., Zhai N., et al. Association between pemphigus vulgaris and human leukocyte antigen in Han nation of northeast China. Chin Med Sci J 2005, 20:166-170.
38. Hashimoto K., Miki Y., Nakata S., et al. HLA-A10 in pemphigus among Japanese. Arch Dermatol 1977, 113:1518-1519.
39. Miyagawa S., Niizeki H., Yamashina Y., et al. Genotyping for HLA-A, B and C alleles in Japanese patients with pemphigus: prevalence of Asian alleles of the HLA-B15 family. Br J Dermatol 2002, 146:52-58.
40. Birol A AR, Tutkak H, Gürgey E. HLA-class 1 and class 2 antigens in Turkish patients with pemphigus. Int J Dermatol 2002;41:79-83.
41. Ahmed A.R., Yunis E.J., Khatri K., et al. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci U S A 1990, 87:7658-7662.
42. Ahmed A.R., Wagner R., Khatri K., et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci U S A 1991, 88:5056-5060.
43. Gazit E., Slomov Y., Goldberg I., et al. HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol 2004, 65:39-46.
44. Bhanusali D., Sachdev A., Rahmanian A., et al. HLA-E*0103 is associated with susceptibility to pemphigus vulgaris. J Invest Dermatol 2008, 128:86. [abstract: 139].
45. Jabri B., de Serre N.P., Cellier C., et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 2000, 188:867-879.
46. Hu D.I.K., Lu L., Sanchirico M.E., et al. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 2004, 5:516-523.
47. Tennakoon D.K., Mehta R.S., Ortega S.B., et al. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J Immunol 2006, 176:7119-7129.
48. Hodgkinson A.D., Millward B.A., Demaine A.G. The HLA-E locus is associated with age at onset and susceptibility to type 1 diabetes mellitus. Hum Immunol 2000, 61:290-295.
49. Park K.S., Park J.S., Nam J.H., et al. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Tissue Antigens 2007, 69:139-144.
50. Sullivan L.C., Clements C.S., Rossjohn J., et al. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 2008, 72:415-424.
51. Jiang H. CL: Qa-1/HLA-E-restricted regulatory CD8+ T cells and self-nonself discrimination: an essay on peripheral T-cell regulation. Hum Immunol 2008, 69:721-727.
52. Lee E., Chow S., Dionsio R., et al. Identification of two distinct CD8+ T cell populations associated with remittent disease in pemphigus vulgaris. J Invest Dermatol 2006, 126:13. [abstract: 76].
53. Vafiadis P., Bennett S.T., Todd J.A., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997, 15:289-292.
54. Garchon H.J., Djabiri F., Viard J.P., et al. Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci U S A 1994, 91:4668-4672.
55. Capon F., Bharkhada J., Cochrane N.E., et al. Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris. Br J Dermatol 2006, 154:67-71.
56. Gibson W.T., Walter M.A., Ahmed A.R., et al. The immunoglobulin heavy chain and disease association: application to pemphigus vulgaris. Hum Genet 1994, 94:675-683.
57. Zitouni M., Martel P., Ben Ayed M., et al. Pemphigus is not associated with allotypic markers of immunoglobulin kappa. Genes Immun 2002, 3:50-52.
58. Niizeki H., Kumagai S., Kanagawa S., et al. Exclusion of the TAP1 and TAP2 genes within the HLA class II region as candidate susceptibility genes to pemphigus in the Japanese population. J Dermatol Sci 2004, 36:122-124.
59. Michou L., Lasbleiz S., Rat A.C., et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A 2007, 104:1649-1654.
60. Farago B., Talian G.C., Komlosi K., et al. Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects. Rheumatol Int 2008, 29:793-796.
61. Howson J.M., Dunger D.B., Nutland S., et al. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 2007, 50:741-746.
62. Balada E., Villarreal-Tolchinsky J., Ordi-Ros J., et al. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. Tissue Antigens 2006, 68:432-438.
63. Sachdev A, Bhanusali D, Zamora MB, et al. PTPN22 1858T is not a risk factor for North American pemphigus vulgaris. Experimental Dermatology 2011, in press.
64. Cheung V.G., Conlin L.K., Weber T.M., et al. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003, 33:422-425.
65. Brem R.B., Yvert G., Clinton R., et al. Genetic dissection of transcriptional regulation in budding yeast. Science 2002, 296:752-755.
66. Sinha A.A., Baumgarten J., Pan H., et al. Gene expression profiling in cutaneous lupus erythematosus. J Invest Dermatol 2002, 119:266. [abstract].
67. Coda A., Sinha A.A. Linking alopecia areata to atopy: evaluation of transcriptionally regulated genes in patient subsets suggests a shared basis for genetic susceptibility. J Invest Dermatol 2010, 130:S92. [abstract: 549].
68. Couzin-Frankel J. Major heart disease genes prove elusive. Science 2010, 328:1220-1221.
69. McClellan J., King M.C. Genetic heterogeneity in human disease. Cell 2010, 141:210-217.
70. Nielsen R. Genomics: in search of rare human variants. Nature 2010, 467:1050-1051.